What do primary and recurrent ovarian cancer patients (OC) expect from their doctors? Final results of a German survey in 608 patients. Background: This report will focus on the translational studies ...
In the study, investigators evaluated the safety of a novel therapy called NSC-CRAd-S-pk7 in patients newly diagnosed with malignant gliomas. NSC-CRAd-S-pk7 is an oncolytic adenovirus delivered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results